Overview

Comparison of Tranexamic to Epsilon Aminocaproic Acid: a Prospective Analysis of Blood Conservation in Cardiac Surgery

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
We designed a prospective double-blinded randomized trial in an attempt to detect a difference between tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) in reducing transfusion in patients undergoing cardiac surgery.
Phase:
N/A
Details
Lead Sponsor:
Loma Linda University
Treatments:
Aminocaproic Acid
Tranexamic Acid